pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,142 catalysts · 5,811 phase readout · 2,325 8k filing · 342 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-03: 0 catalysts2026-08-04: 0 catalysts2026-08-05: 0 catalysts2026-08-06: 0 catalysts2026-08-07: 16 catalysts2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 11 catalysts2026-08-11: 7 catalysts2026-08-12: 13 catalysts2026-08-13: 11 catalysts2026-08-14: 3 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 1 catalyst2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 9 catalysts2026-10-29: 17 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,811
  • 8k filing2,325
  • earnings342
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›RECRUITINGphase readoutNCT05363280: Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment

Sponsor: Advenchen Pharmaceuticals, LLC.. Phase: PHASE2. Conditions: Small Cell Lung Cancer, Renal Cell Carcinoma (RCC), Non-Small Cell Lung

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04648280: Safety and Pharmacokinetics Evaluation of Fostemsavir + (OBT) in HIV-1 Infected Children and Adolescents Who Are Failing Their cART and Have Dual- or Triple-class Antiretroviral Resistance

Sponsor: PENTA Foundation. Phase: PHASE1. Conditions: HIV Infections With Multi Drug Resistant Virus

full page →ctgov ↗
›RECRUITINGphase readoutNCT07435779: Autologous CAR-T Cell Therapy for Refractory and Relapsing Ulcerative Colitis: A Single-Center Exploratory Study

Sponsor: Hebei Senlang Biotechnology Inc., Ltd.. Phase: EARLY_PHASE1. Conditions: UC

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05907096: ARGX-117 in Deceased Donor Kidney Transplant Recipients at Risk for Delayed Graft Function

Sponsor: argenx. Phase: PHASE2. Conditions: Delayed Graft Function

full page →ctgov ↗
›COMPLETEDphase readoutNCT01897688: A Phase 3 Single Center Study of Islet Transplantation in Non-uremic Diabetic Patients

Sponsor: Northwestern University. Phase: PHASE3. Conditions: Type 1 Diabetes, Severe Hypoglycemic Unawareness

full page →ctgov ↗
›RECRUITINGphase readoutNCT05431088: A Phase 2/3 Study in Adult and Adolescent Participants With SCD

Sponsor: Pfizer. Phase: PHASE2. Conditions: Sickle Cell Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT06016088: A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection

Sponsor: Respirion Pharmaceuticals Pty Ltd. Phase: PHASE1. Conditions: Cystic Fibrosis Lung, Respiratory Infections, Recurrent, Chronic, Pseudomonas Aeruginosa

full page →ctgov ↗
›RECRUITINGphase readoutNCT04933903: BrUOG 397: NEO Rad (LOW): Neoadjuvant Low Dose Stereotactic Body Radiotherapy, Ipilimumab and Nivolumab

Sponsor: Brown University. Phase: PHASE2. Conditions: Non Small Cell Lung Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07562061: mulTiplex Immunoassay qualiTy assuRance Panel

Sponsor: St George's, University of London. Phase: . Conditions: Group B Strep Infection

full page →ctgov ↗
›COMPLETEDphase readoutNCT00861705: Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery

Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Male Breast Carcinoma, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIB Breast Cancer AJCC v6 and v7, Stage IIIA Breast Cancer AJCC v7, Triple-Negative Breast Carcinoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT07598994: Topical Capsaicin Versus Diclofenac for Chronic Temporomandibular Joint-Related Pain

Sponsor: Istanbul University. Phase: NA. Conditions: Temporomandibular Disorders (TMD), Temporomandibular Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT07061366: The Use of the Bambi-Belt in Exteremly Preterm Infants: an Implementation Study.

Sponsor: Maxima Medical Center. Phase: . Conditions: Preterm, Monitoring

full page →ctgov ↗
›COMPLETEDphase readoutNCT03879694: Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine Tumors

Sponsor: Roswell Park Cancer Institute. Phase: PHASE1. Conditions: Lung Atypical Carcinoid Tumor, Lung Typical Carcinoid Tumor, Metastatic Pancreatic Neuroendocrine Tumor

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06706622: A Trial of Amlenetug (Lu AF82422) in Participants With Multiple System Atrophy (MSA)

Sponsor: H. Lundbeck A/S. Phase: PHASE3. Conditions: Multiple System Atrophy

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03849651: TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies

Sponsor: St. Jude Children's Research Hospital. Phase: PHASE2. Conditions: Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS), NK-Cell Leukemia, Hodgkin Lymphoma, Non Hodgkin Lymphoma (NHL), Juvenile Myelomonocytic Leukemia (JMML), Chronic Myeloid Leukemia (CML)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07519551: Serum Myostatin and Irisin Levels in Postmenopausal Women: Association With Bone Mineral Density and Muscle Strength

Sponsor: Kanuni Sultan Suleyman Training and Research Hospital. Phase: . Conditions: Osteoporosis, Osteopenia

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03466151: RESOLUTE ONYX China RCT Study

Sponsor: Medtronic Vascular. Phase: NA. Conditions: Ischemic Heart Disease, Stenotic Coronary Lesion, Cardiovascular Diseases, Arteriosclerosis, Coronary Artery Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT04423029: A Study of DF6002 Alone and in Combination With Nivolumab

Sponsor: Dragonfly Therapeutics. Phase: PHASE1. Conditions: Solid Tumors

full page →ctgov ↗
›COMPLETEDphase readoutNCT06958653: Gamified Digital Balance Assessment for Older Adults in Community Settings: Development, Validation, and User Experience Evaluation in a Mixed Methods Study

Sponsor: Shanghai Jiao Tong University School of Medicine. Phase: NA. Conditions: ELDERLY PEOPLE, Fall Prevention, Digital Health

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07402837: Creating a Flexible Curriculum Tool for Pediatric Palliative Care Rotating Learners

Sponsor: Children's National Research Institute. Phase: NA. Conditions: Palliative Care Education

full page →ctgov ↗
›COMPLETEDphase readoutNCT05491837: Device-induced Intermittent Hypoxia in Persons With Incomplete Spinal Cord Injury

Sponsor: Riphah International University. Phase: NA. Conditions: Incomplete Spinal Cord Injury

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT05479045: A Combination Therapy Strategy to Prevent Anti-PD-1 Therapy Resistance in Metastatic Ovarian Cancer Patients

Sponsor: Georgetown University. Phase: PHASE2. Conditions: Ovarian Cancer Stage IV, Ovarian Cancer Stage III, Ovarian Cancer Stage 3

full page →ctgov ↗
›SUSPENDEDphase readoutNCT07260045: The Effects of Chiropractic on Adults With Depression

Sponsor: Life University. Phase: NA. Conditions: Depression Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT07394972: Absorption of Iron From Stabilized Lactoferrin: A Study in Women With Iron Deficiency

Sponsor: Nicole Stoffel. Phase: NA. Conditions: Iron Deficiency (Without Anemia)

full page →ctgov ↗
›RECRUITINGphase readoutNCT05970172: A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease

Sponsor: Astellas Pharma Global Development, Inc.. Phase: PHASE3. Conditions: Chronic Kidney Disease, Renal Anemia

full page →ctgov ↗
›COMPLETEDphase readoutNCT05979272: TECH App Marijuana Use Intervention for Court-Involved Adolescents

Sponsor: Northwestern University. Phase: NA. Conditions: Cannabis Use, Adolescent

full page →ctgov ↗
›COMPLETEDphase readoutNCT03452072: Efficacy and Safety of 0.25% Timolol Gel in Healing Surgical Open Wounds

Sponsor: Brigham and Women's Hospital. Phase: PHASE2. Conditions: Wound of Skin, Wound Heal, Wound Open, Surgical Wound

full page →ctgov ↗
›RECRUITINGphase readoutNCT07135895: The ArtixASCEND Study

Sponsor: Inari Medical. Phase: NA. Conditions: Acute Lower Limb Arterial Occlusion

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT06040645: Outcomes of Urinary Incontinence Treatment in Primary Care: APP Co-Management and Electronic Consult

Sponsor: University of California, San Diego. Phase: NA. Conditions: Urinary Incontinence

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06323772: Natural History Study in Patients With PDE6A-, PDE6B- and RHO-linked Retinitis Pigmentosa

Sponsor: University Hospital Tuebingen. Phase: . Conditions: Retinitis Pigmentosa

full page →ctgov ↗
›RECRUITINGphase readoutNCT06118372: Recombinant vWF Concentrate and ECMO

Sponsor: University of Virginia. Phase: PHASE1. Conditions: Bleeding Disorder

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07431372: Validation of the Shared Happiness Index in Multidisciplinary Primary Care Practices ( Be aPi )

Sponsor: Centre Hospitalier Universitaire de la Réunion. Phase: . Conditions: Well Being

full page →ctgov ↗
›COMPLETEDphase readoutNCT05916495: An Evaluation of Remote Care (Questionnaire+Hybrid) in Patients Who Are Post-lung Transplant

Sponsor: University of Manchester. Phase: NA. Conditions: Lung Transplant; Complications

full page →ctgov ↗
›RECRUITINGphase readoutNCT06526195: Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

Sponsor: Abbott Medical Devices. Phase: NA. Conditions: Heart Failure, Heart Diseases, Cardiovascular Diseases, Pulmonary Hypertension

full page →ctgov ↗
›RECRUITINGphase readoutNCT07248839: A Study to Assess the Drug Levels and Safety of BMS-986435 in Participants With Normal Hepatic Function and Participants With Different Degrees of Hepatic Impairment

Sponsor: Bristol-Myers Squibb. Phase: PHASE1. Conditions: Healthy Volunteers, Hepatic Impairment

full page →ctgov ↗
›COMPLETEDphase readoutNCT02117375: EMISEP : Early Spinal Cord Lesions and Late Disability in Relapsing Remitting Multiple Sclerosis Patients

Sponsor: Rennes University Hospital. Phase: NA. Conditions: Multiple Sclerosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT05332275: A Media Parenting Prevention Intervention

Sponsor: University of Florida. Phase: NA. Conditions: Substance Related Problem

full page →ctgov ↗
›COMPLETEDphase readoutNCT04138277: A Study to Assess the Long-term Safety and Efficacy of ATB200/AT2221 in Adult Subjects With Late-Onset Pompe Disease (LOPD)

Sponsor: Amicus Therapeutics. Phase: PHASE3. Conditions: Pompe Disease (Late-onset)

full page →ctgov ↗
›COMPLETEDphase readoutNCT03910075: Perinatal Arterial Stroke: A Multi-site RCT of Intensive Infant Rehabilitation (I-ACQUIRE)

Sponsor: Virginia Polytechnic Institute and State University. Phase: PHASE3. Conditions: Perinatal Stroke, Hemiparesis

full page →ctgov ↗
›COMPLETEDphase readoutNCT03998501: fMRI to Examine the Effect of CBTm to Increase Resiliency for PTSD

Sponsor: University of Manitoba. Phase: NA. Conditions: Stress Disorders, Post-Traumatic

full page →ctgov ↗
›RECRUITINGphase readoutNCT05923801: Changing Tactics? Optimizing ECT in Difficult-to-treat Depression

Sponsor: Universitaire Ziekenhuizen KU Leuven. Phase: NA. Conditions: Depression

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT06054230: Genomic Sequencing for Evaluation of Fetal Structural Anomalies

Sponsor: University of California, San Francisco. Phase: NA. Conditions: Fetal Structural Anomalies

full page →ctgov ↗
›COMPLETEDphase readoutNCT05747430: SteRilizing Eye SoLution to ImprovE Patient ComFort (RELIEF)

Sponsor: iRenix Medical, Inc.. Phase: PHASE2. Conditions: Retinal Disease

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07465328: Studying the Impairment of Stroke and Sarcopenia Patients Using Maximum Voluntary Contractions of the Leg Joints.

Sponsor: Vrije Universiteit Brussel. Phase: NA. Conditions: Sarcopenia, Stroke

full page →ctgov ↗
›COMPLETEDphase readoutNCT02792465: A Study of Investigational Drug CFI-402257 in Patients With Advanced Solid Tumors

Sponsor: University Health Network, Toronto. Phase: PHASE1. Conditions: Advanced Solid Cancers, Breast Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07182565: Hypofractionated Radiotherapy Plus Immunochemotherapy for Neoadjuvant Treatment of Gastroesophageal Junction Adenocarcinoma

Sponsor: West China Hospital. Phase: PHASE1. Conditions: Gastroesophageal Junction Adenocarcinoma, Hypofractionated Radiotherapy

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07216365: Caffeine Optimization for Oxygen Saturation Index in ELBW Infants

Sponsor: University of Rochester. Phase: PHASE2. Conditions: Neonatal Apnea, Infants

full page →ctgov ↗
›COMPLETEDphase readoutNCT05167565: Longitudinal Development of Behavior and Its Underlying Neural Correlates in Human Infants

Sponsor: Hospices Civils de Lyon. Phase: NA. Conditions: Healthy Volunteers

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05345171: Clinical Study of DTX301 AAV-Mediated Gene Transfer for Ornithine Transcarbamylase (OTC) Deficiency

Sponsor: Ultragenyx Pharmaceutical Inc. Phase: PHASE3. Conditions: OTC Deficiency

full page →ctgov ↗
›COMPLETEDphase readoutNCT05258071: A Clinical Study Evaluating Efficacy of Pirepemat on Falls Frequency in Patients With Parkinson's Disease (PD)

Sponsor: Integrative Research Laboratories AB. Phase: PHASE2. Conditions: Parkinson Disease

full page →ctgov ↗
← prev
page 122 of 163
next →